Literature DB >> 2864641

Antistereotypic effects of dopamine D-1 and D-2 antagonists after intrastriatal injection in rats. Pharmacological and regional specificity.

J Arnt.   

Abstract

Apomorphine antagonistic effects of a range of dopamine (DA) antagonists were studied after intracerebral and after peripheral injection. Inhibitory activity was found selectively within the ventral striatum with a D-1 antagonist (SCH 23390), D-2 antagonists (benzamides, butyrophenones) and mixed D-1/D-2 antagonists (thioxanthenes, phenothiazines), whereas alpha-adrenoceptor antagonists, muscarinic- and serotonin S2-antagonists were ineffective. Great differences in absolute potencies and in peripheral versus intrastriatal potency ratios were observed. High peripheral versus central selectivity ratios and high intrastriatal potencies were found with the hydrophilic compounds (-)-sulpiride, veralipride and domperidone which do not readily cross the blood-brain barrier. High intrastriatal potency was also observed for the benzamide, YM 09151-2, haloperidol and spiroperidol although these compounds had lower peripheral versus intrastriatal selectivity ratios. Neuroleptic potency after intracerebral administration did not depend solely on DA receptor affinity but additionally on physicochemical properties. On the basis of the peripheral vs. intrastriatal potency ratios, it is concluded that only few of the neuroleptics tested in this study are suited for topographical studies of DA receptor function using intracerebral injection but that (-)-sulpiride is one example combining high potency, high central selectivity, high DA D-2 receptor specificity, stereoselectivity and long duration of action. The site-selectivity of apomorphine-antagonistic effects was further studied using (-)-sulpiride as a model compound. Inhibitory activity against oral stereotypy was preferentially found after injection into the ventral striatum, whereas the low-component patterns of apomorphine stereotypy (sniffing, rearing, motility) were blocked equally well in the ventral striatum and nucleus accumbens.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2864641     DOI: 10.1007/bf00499901

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  24 in total

Review 1.  Multiple receptors for dopamine.

Authors:  J W Kebabian; D B Calne
Journal:  Nature       Date:  1979-01-11       Impact factor: 49.962

2.  Depression of exploratory activity by clonidine in rats as a model for the detection of relative pre- and postsynaptic central noradrenergic receptor selectivity of alpha-adrenolytic drugs.

Authors:  A Delini-Stula; P Baumann; O Büch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-06       Impact factor: 3.000

Review 3.  A systematic study of the pharmacological activities of dopamine antagonists.

Authors:  C J Niemegeers; P A Janssen
Journal:  Life Sci       Date:  1979-06-11       Impact factor: 5.037

4.  Selective binding of YM-09151-2, a new potent neuroleptic, to D2-dopaminergic receptors.

Authors:  M Terai; S Usuda; I Kuroiwa; O Noshiro; H Maeno
Journal:  Jpn J Pharmacol       Date:  1983-08

5.  In vivo selectivity of prazosin but not of WB4101 for postsynaptic alpha-1 adrenoceptors.

Authors:  R Massingham; M L Dubocovich; N B Shepperson; S Z Langer
Journal:  J Pharmacol Exp Ther       Date:  1981-05       Impact factor: 4.030

6.  Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors.

Authors:  J E Leysen; F Awouters; L Kennis; P M Laduron; J Vandenberk; P A Janssen
Journal:  Life Sci       Date:  1981-03-02       Impact factor: 5.037

7.  Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics.

Authors:  A V Christensen; J Arnt; J Hyttel; J J Larsen; O Svendsen
Journal:  Life Sci       Date:  1984-04-16       Impact factor: 5.037

8.  Differential inhibition by dopamine D-1 and D-2 antagonists of circling behaviour induced by dopamine agonists in rats with unilateral 6-hydroxydopamine lesions.

Authors:  J Arnt; J Hyttel
Journal:  Eur J Pharmacol       Date:  1984-07-13       Impact factor: 4.432

9.  Further evidence that 3H-cis(Z)flupenthixol binds to the adenylate cyclase-associated dopamine receptor (D-1) in rat corpus striatum.

Authors:  J Hyttel
Journal:  Psychopharmacology (Berl)       Date:  1980-01       Impact factor: 4.530

10.  Potent lipophilic substituted benzamide drugs are not selective D-1 dopamine receptor antagonists in the rat.

Authors:  S Fleminger; H van de Waterbeemd; N M Rupniak; C Reavill; B Testa; P Jenner; C D Marsden
Journal:  J Pharm Pharmacol       Date:  1983-06       Impact factor: 3.765

View more
  11 in total

Review 1.  What makes you tic? Translational approaches to study the role of stress and contextual triggers in Tourette syndrome.

Authors:  Sean C Godar; Marco Bortolato
Journal:  Neurosci Biobehav Rev       Date:  2016-12-08       Impact factor: 8.989

2.  Absent movement-related cortical potentials in children with primary motor stereotypies.

Authors:  Elise Houdayer; Jessica Walthall; Beth A Belluscio; Sherry Vorbach; Harvey S Singer; Mark Hallett
Journal:  Mov Disord       Date:  2013-11-20       Impact factor: 10.338

3.  Synergistic blockade of some dopamine-mediated behaviours by (-)-sulpiride and SCH 23390 in the rat.

Authors:  R Dall'Olio; P Roncada; A Vaccheri; O Gandolfi; N Montanaro
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  8-[3H]hydroxy-2-(di-n-propylamino) tetralin binding sites in goldfish retina.

Authors:  L Lima; C Schmeer; M Urbina
Journal:  Neurochem Res       Date:  1994-03       Impact factor: 3.996

5.  Induction of oral stereotypy following amphetamine microinjection into a discrete subregion of the striatum.

Authors:  A E Kelley; C G Lang; A M Gauthier
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

Review 6.  Animal models of tic disorders: a translational perspective.

Authors:  Sean C Godar; Laura J Mosher; Giuseppe Di Giovanni; Marco Bortolato
Journal:  J Neurosci Methods       Date:  2014-09-20       Impact factor: 2.390

7.  Functional regulation by dopamine receptors of serotonin release from the rat hippocampus: in vivo microdialysis study.

Authors:  M Matsumoto; M Yoshioka; H Togashi; T Ikeda; H Saito
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-05       Impact factor: 3.000

8.  Enhanced oral activity responses to intrastriatal SKF 38393 and m-CPP are attenuated by intrastriatal mianserin in neonatal 6-OHDA-lesioned rats.

Authors:  A Plech; R Brus; J H Kalbfleisch; R M Kostrzewa
Journal:  Psychopharmacology (Berl)       Date:  1995-06       Impact factor: 4.530

9.  Dissociation of nicotinic α7 and α4/β2 sub-receptor agonists for enhancing learning and attentional filtering in nonhuman primates.

Authors:  Marzyeh Azimi; Mariann Oemisch; Thilo Womelsdorf
Journal:  Psychopharmacology (Berl)       Date:  2019-12-21       Impact factor: 4.530

Review 10.  Dopaminergic control of cognitive flexibility in humans and animals.

Authors:  Marianne Klanker; Matthijs Feenstra; Damiaan Denys
Journal:  Front Neurosci       Date:  2013-11-05       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.